Study Identifies Genetic and Neural Basis of Aggression Differences Across Mouse Strains
Researchers examining seven genetically distinct mouse strains found large differences in aggressive behavior that correlate with anxiety levels and are controlled by specific brain regions. The study identified the ventrolateral ventromedial hypothalamus (VMHvl) as a key neural site where genetic differences in aggression are implemented, with pharmacological and genetic manipulations confirming causal relationships. These findings suggest aggression is substantially shaped by genetic factors and could inform understanding of aggression variation in other species.
A bioRxiv preprint reports that male mice from seven genetically defined strains display substantial differences in aggressive behavior, with cross-strain variation tightly correlated to anxiety levels—though this correlation does not hold within individual strains. The researchers demonstrated that pharmacologically elevating anxiety in high-aggression strains reduces aggressive behavior, establishing a causal link between the two traits. By examining neural properties in the ventrolateral ventromedial hypothalamus (VMHvl), they found that synaptic and cellular differences in this brain region largely explain cross-strain variation in aggression. Chemogenetic experiments further confirmed the causal role of this region: artificially increasing VMHvl excitability enhanced attack behavior in a naturally low-aggression strain. The findings suggest that genetic control of innate aggression operates through specific neural mechanisms in the hypothalamus.
What's missing
The preprint does not discuss potential limitations of the mouse model for understanding human aggression, nor does it address whether findings generalize to female mice or other species. The study's sample sizes per strain and statistical power are not detailed in the abstract.
What different sources said
- bioRxivCenter
Hypothalamic Representation of Aggressiveness across Mouse Strains
Related
Study Identifies Galectin-3's Role in Gastric Metaplasia Development Through Cathartocytosis
Researchers found that galectin-3, a protein upregulated in precancerous tissue changes, facilitates a cellular process called cathartocytosis that promotes the development of spasmolytic polypeptide expressing metaplasia (SPEM) in the stomach. Galectin-3 is abnormally expressed alongside sulfated mucins in high-risk precancerous conditions like Barrett's esophagus and intestinal metaplasia. The findings suggest galectin-3 may represent a therapeutic target for preventing progression from normal tissue to metaplastic and potentially cancerous states.
Study reveals spermatogonial stem cell clones don't follow random drift patterns in zebrafish
Researchers used CRISPR barcoding to track how spermatogonial stem cells (SSCs) contribute to sperm production across a zebrafish's lifetime, finding that clonal dynamics deviate significantly from neutral drift models. The study developed a mathematical framework showing that larger clones tend to drift at higher rates, suggesting non-random selection pressures. These findings have implications for understanding allele transmission and male fertility across the reproductive lifespan.
Researchers identify synthetic lethal TYMS inhibitor effective against ATRX-deficient cells
Scientists developed a phenotype-first screening approach that identified PP12, a covalent fragment that selectively kills ATRX-deficient cells by inhibiting thymidylate synthase (TYMS). The study combines covalent fragment screening, chemoproteomics, and genetic analysis to link drug phenotypes to specific cellular targets. This work establishes a generalizable methodology for discovering synthetic lethal drug candidates in cancer cells with specific genetic deficiencies.